Skip to content
Thursday, November 12, 2026
SilverPortal

The Zimbabwean Government Declines ‘One-Sided’ American Healthcare Assistance Agreement Over Information Fears

Health funding illustration
The offered US funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a significant US healthcare agreement worth $367m (£272m) over five years due to Washington's demand for confidential data.

The decision was revealed following a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".

A government spokesman has since clarified that the United States was requesting genetic material for research and commercial purposes but refused to guarantee the benefits from any future treatments.

"We will now turn to the challenging and unfortunate process of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the US had donated more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for more negotiations to reach a deal suitable to both sides so the country's vital HIV programme can continue.

Broader Background

This development follows a comparable case in Kenya, where a court halted a related deal with the US following legal challenges were filed about the security of Kenyans' health data.

Since returning to office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance openness and accountability.

As per statements, Sixteen nations in Africa have so far agreed to similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration might have yielded significant advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.

"Effectively, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our people if a new pandemic emerge."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously set up through the global organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.

"This system is intended to ensure that when a country contributes its samples, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."

The government's concerns over the US deal "are not meant as hostility towards the US," he added.

"We welcome ongoing dialogue with our American counterparts on how subsequent co-operation could be structured in a way that honours the independence and dignity of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but recommended that negotiations must proceed considering a large portion of the country's HIV programmes relied on external financing.

"If technical issues arise, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.

The situation highlights the ongoing challenges between accepting vital international aid and protecting local interests in an increasingly data-driven world.

About the author

Theresa Roman

A financial analyst with over 15 years specializing in precious metals markets and wealth management strategies.

SilverPortal

Type to search articles.